SCHEMBL5778867

SCHEMBL5778867

CC(C)(C)OC(=O)N1CCc2ccc(N)c(Cl)c2CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.55
ESR2 Q92731 1/20 0.53
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ADORA1 P30542 2/20 0.44
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.42
STS P08842 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ACACB O00763 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4876652 0.88 NR1H2 (0.56) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL10228372 0.85 NR1H2 (0.55) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL1294353 0.83 MAPT (0.43) MAPTKDM4EPOLBALDH1A1LMNA
SCHEMBL506203 0.83 ESR2 (0.57) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL20286648 0.82 NR1H2 (0.54) NR1H2ESR2ADORA1MAPTKDM4E
SCHEMBL4871982 0.81 NR1H2 (0.56) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL507329 0.80 ESR2 (0.53) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL2254913 0.79 ESR2 (0.50) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL20573212 0.79 ESR2 (0.55) NR1H2ESR2MEN1KMT2AADORA1
SCHEMBL25256247 0.79 NR1H2 (0.60) NR1H2ESR2ADORA1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487801-B1 7-ARYLSULFONAMIDO-2,3,4,5-TETRAHYDRO-1H-BENZO¬D|AZEPINE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY FOR THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2006-04-19 EP disclosed
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders GLAXO GROUP LIMITED (GB) 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders HTR6, HTR7, HTR2A NR1H2 244/4885ESR2 794/4885MEN1 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.